Liver impairment in critical illness and sepsis: the dawn of new biomarkers?
作者信息
Kluge Martin, Tacke Frank
机构信息
Department of Hepatology & Gastroenterology, Charité University Medicine Berlin, Berlin, Germany.
出版信息
Ann Transl Med. 2019 Dec;7(Suppl 8):S258. doi: 10.21037/atm.2019.12.79.
Abstract
摘要
相似文献
1
Liver impairment in critical illness and sepsis: the dawn of new biomarkers?危重病和脓毒症中的肝功能损害：新型生物标志物的曙光？
Ann Transl Med. 2019 Dec;7(Suppl 8):S258. doi: 10.21037/atm.2019.12.79.
2
Cholestatic liver (dys)function during sepsis and other critical illnesses.脓毒症和其他危重病期间的胆汁淤积性肝功能（障碍）。
Intensive Care Med. 2016 Jan;42(1):16-27. doi: 10.1007/s00134-015-4054-0. Epub 2015 Sep 21.
3
The Role of Adipokines as Circulating Biomarkers in Critical Illness and Sepsis.脂肪细胞因子作为危重病和脓毒症的循环生物标志物的作用。
Int J Mol Sci. 2019 Sep 28;20(19):4820. doi: 10.3390/ijms20194820.
4
Protein C in critical illness.危重症中的蛋白C
Am J Health Syst Pharm. 2009 Jun 15;66(12):1089-96. doi: 10.2146/ajhp080276.
5
Comparison of qSOFA with current emergency department tools for screening of patients with sepsis for critical illness.qSOFA 与现有急诊科工具在筛查脓毒症患者是否发生重症的比较。
Emerg Med J. 2018 Jun;35(6):350-356. doi: 10.1136/emermed-2017-207383. Epub 2018 May 2.
6
Cholestatic Alterations in the Critically Ill: Some New Light on an Old Problem.危重病患者的胆汁淤积性改变：一个老问题的新启示。
Chest. 2018 Mar;153(3):733-743. doi: 10.1016/j.chest.2017.08.018. Epub 2017 Aug 26.
7
Diagnostic and prognostic biomarkers of sepsis in critical care.重症监护中脓毒症的诊断和预后生物标志物。
J Antimicrob Chemother. 2011 Apr;66 Suppl 2:ii33-40. doi: 10.1093/jac/dkq523.
8
The Role of Liver Function in the Setting of Cirrhosis with Chronic Infection and Critical Illness.
Crit Care Nurs Clin North Am. 2017 Mar;29(1):37-50. doi: 10.1016/j.cnc.2016.09.006. Epub 2016 Dec 14.
9
Biomarkers and Precision Medicine: State of the Art.生物标志物与精准医学：现状。
Crit Care Clin. 2020 Jan;36(1):155-165. doi: 10.1016/j.ccc.2019.08.012. Epub 2019 Oct 22.
10
Interpreting Laboratory Tests in Infection: Making Sense of Biomarkers in Sepsis and Systemic Inflammatory Response Syndrome for Intensive Care Unit Patients.解读感染中的实验室检查：理解重症监护病房患者脓毒症和全身炎症反应综合征中的生物标志物
Crit Care Nurs Clin North Am. 2017 Mar;29(1):119-130. doi: 10.1016/j.cnc.2016.09.004. Epub 2016 Dec 14.
引用本文的文献
1
Artificial liver support with Cytosorb and continuous veno-venous hemodiafiltration versus advanced organ support (ADVOS) for critically ill patients with hyperbilirubinemia and acute-on-chronic liver failure (ACLF).采用Cytosorb和持续静脉-静脉血液透析滤过的人工肝支持与用于高胆红素血症和慢加急性肝衰竭（ACLF）重症患者的高级器官支持（ADVOS）的对比研究
BMC Nephrol. 2025 Aug 4;26(1):432. doi: 10.1186/s12882-025-04342-6.
2
Putative biomarkers of hepatic dysfunction in critically ill sepsis patients.危重症脓毒症患者肝功能障碍的潜在生物标志物。
Clin Exp Med. 2025 Jan 3;25(1):28. doi: 10.1007/s10238-024-01545-3.
3
Bioinformatics study of the TNFRSF1A mechanism involved in acute liver injury in sepsis through the mTOR signaling pathway.通过mTOR信号通路对脓毒症急性肝损伤中TNFRSF1A机制的生物信息学研究。
Histol Histopathol. 2025 Mar;40(3):401-409. doi: 10.14670/HH-18-789. Epub 2024 Jul 3.
4
Acute liver failure in pregnancy.妊娠急性肝衰竭。
Indian J Gastroenterol. 2024 Apr;43(2):325-337. doi: 10.1007/s12664-024-01571-9. Epub 2024 May 1.
5
The Prognostic Value of a Liver Function Test Using Indocyanine Green (ICG) Clearance in Patients with Multiple Organ Dysfunction Syndrome (MODS).使用吲哚菁绿（ICG）清除率的肝功能测试在多器官功能障碍综合征（MODS）患者中的预后价值。
J Clin Med. 2024 Feb 11;13(4):1039. doi: 10.3390/jcm13041039.
6
Hemoadsorption Therapy for Critically Ill Patients with Acute Liver Dysfunction: A Meta-Analysis and Systematic Review.急性肝功能不全重症患者的血液吸附治疗：一项荟萃分析与系统评价
Biomedicines. 2023 Dec 27;12(1):67. doi: 10.3390/biomedicines12010067.
7
Population Pharmacokinetic Modeling and Dose Optimization of Acetaminophen and its Metabolites Following Intravenous Infusion in Critically ill Adults.重症成人静脉输注对乙酰氨基酚及其代谢物的群体药代动力学建模与剂量优化
Eur J Drug Metab Pharmacokinet. 2023 Sep;48(5):531-540. doi: 10.1007/s13318-023-00841-9. Epub 2023 Jun 30.
8
ANALGESIC EFFECT OF TRAMADOL IS NOT ALTERED BY POSTOPERATIVE SYSTEMIC INFLAMMATION AFTER MAJOR ABDOMINAL SURGERY.曲马多的镇痛效果不受腹部大手术后全身炎症反应的影响。
Acta Clin Croat. 2021 Jun;60(2):268-275. doi: 10.20471/acc.2021.60.02.13.
9
International Normalized Ratio to Albumin Ratio (PTAR): An Objective Risk Stratification Tool in Patients with Sepsis.国际标准化比值与白蛋白比值（PTAR）：脓毒症患者的一种客观风险分层工具。
Int J Gen Med. 2021 May 12;14:1829-1841. doi: 10.2147/IJGM.S305085. eCollection 2021.
本文引用的文献
1
Biomarker-assisted identification of sepsis-related acute liver impairment: a frequent and deadly condition in critically ill patients.生物标志物辅助鉴定与脓毒症相关的急性肝损伤：危重症患者中一种常见且致命的病症。
Clin Chem Lab Med. 2019 Aug 27;57(9):1422-1431. doi: 10.1515/cclm-2018-1350.
2
Hyaluronic Acid Is a Biomarker for Allograft Dysfunction and Predicts 1-Year Graft Loss After Liver Transplantation.透明质酸是同种异体移植物功能障碍的生物标志物，并可预测肝移植后1年移植物丢失情况。
Transplant Proc. 2018 Dec;50(10):3635-3643. doi: 10.1016/j.transproceed.2018.09.018. Epub 2018 Sep 11.
3
Liver Fibrosis Markers Improve Prediction of Outcome in Non-Acetaminophen-Associated Acute Liver Failure.肝纤维化标志物可改善非对乙酰氨基酚相关性急性肝衰竭预后的预测。
Hepatol Commun. 2018 Sep 21;2(11):1331-1343. doi: 10.1002/hep4.1233. eCollection 2018 Nov.
4
Index serum hyaluronic acid independently and accurately predicts mortality in patients with liver disease.血清透明质酸指数可独立且准确地预测肝病患者的死亡率。
Aliment Pharmacol Ther. 2018 Aug;48(4):423-430. doi: 10.1111/apt.14897. Epub 2018 Jul 4.
5
The intensive care unit course and outcome in acute-on-chronic liver failure are comparable to other populations.重症监护病房的急性慢性肝衰竭患者的治疗过程和结果与其他人群相当。
J Hepatol. 2018 Oct;69(4):803-809. doi: 10.1016/j.jhep.2018.04.025. Epub 2018 May 4.
6
Liver macrophages in tissue homeostasis and disease.组织稳态和疾病中的肝巨噬细胞。
Nat Rev Immunol. 2017 May;17(5):306-321. doi: 10.1038/nri.2017.11. Epub 2017 Mar 20.
7
Liver - guardian, modifier and target of sepsis.肝脏——脓毒症的保护者、调节剂和靶标。
Nat Rev Gastroenterol Hepatol. 2017 Jan;14(1):55-66. doi: 10.1038/nrgastro.2016.168. Epub 2016 Dec 7.
8
Cholestatic liver (dys)function during sepsis and other critical illnesses.脓毒症和其他危重病期间的胆汁淤积性肝功能（障碍）。
Intensive Care Med. 2016 Jan;42(1):16-27. doi: 10.1007/s00134-015-4054-0. Epub 2015 Sep 21.
9
Hyaluronic acid as a non-invasive biomarker of liver fibrosis.透明质酸作为肝纤维化的一种非侵入性生物标志物。
Clin Biochem. 2016 Feb;49(3):302-15. doi: 10.1016/j.clinbiochem.2015.07.019. Epub 2015 Jul 17.
10
Outcome of patients with cirrhosis requiring mechanical ventilation in ICU.ICU 中需要机械通气的肝硬化患者的转归。
J Hepatol. 2014 Mar;60(3):570-8. doi: 10.1016/j.jhep.2013.11.012. Epub 2013 Nov 23.
Zotero 插件